Sandoz Launches Pre-Filled Epinephrine Injection for Type 1 Allergic Reactions in the US

 Sandoz Launches Pre-Filled Epinephrine Injection for Type 1 Allergic Reactions in the US

Sandoz Launches Pre-Filled Epinephrine Injection for Type 1 Allergic Reactions in the US

Shots:

  • Sandoz launches Symjepi (epinephrine, 0.3mg & 0.15mg) injection for the emergency treatment of Type 1 allergic reactions including anaphylaxis and will be available in adult and pediatric doses at pharmacy retail outlets in the US
  • The launch of Symjepi will address ongoing epinephrine auto-injector shortage, meeting the demands of patients with type 1 allergic reactions leading to death if left untreated
  • Symjepi is a single-dose, pre-filled syringe and device combination available as a cost-effective treatment option with a compact and user-friendly design for Type 1 including anaphylaxis to stinging and biting insects, allergen immuno-therapy, foods, drugs, diagnostic testing substances

Click here to read full press release/ article | Ref: Sandoz | Image: Snack Safely

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post